/NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ Trading Symbol: ELR (TSX); EPS (JSE) VANCOUVER, BC, July 22, 2020 /CNW/ - Eastern Platinum Limited ("Eastplats" or the ...
SAINT LAURENT, Quebec, Jan. 09, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”) a leader in pharmaceutical films, today announced that it has entered into a Feasibility ...
Swampscott has taken the next steps on the road to producing a Hadley Elementary School feasibility study. Last week, the Swampscott Board of Selectmen signed off on a feasibility study agreement ...
The U.S. Army Corps of Engineers, Kansas City District, and the State of Missouri partnered to sign a Feasibility Cost Share Agreement for a feasibility study on the area of river miles 515 to 450, ...
ASHDOD, Israel , Dec. 11, 2019 /PRNewswire/ -- Cannassure Therapeutics Ltd (TASE: CSURE) ("Cannassure"), an Israel based developer and producer of innovative medical cannabis products, and Lipidor AB ...
CHEEKTOWAGA, N.Y. — Buffalo Niagara Waterkeeper (BNW) and the US Army Corps of Engineers Buffalo District (USACE) have co-signed an agreement for a feasibility study, aimed at cleaning up Scajaquada ...
SAINT LAURENT, Quebec, Nov. 09, 2022 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx”), a leader in pharmaceutical films, today announced that it has entered ...
Sep. 6—JAMESTOWN — The Stutsman County Commission unanimously approved an engineering services agreement on Tuesday, Sept. 3, with Houston Engineering Inc. for what will result in a feasibility study ...
VANCOUVER, BC, Dec. 2, 2024 /PRNewswire/ - Blue Sky Uranium Corp. (BSK:CA) (FSE: MAL2) (OTC: BKUCF), ("Blue Sky" or the "Company") is pleased to announce that the Company has entered into a definitive ...
SACRAMENTO, Calif. (June 25, 2010) - Sacramento District Commander Col. Tom Chapman joined California's Central Valley Flood Protection Board President Ben Carter and San Joaquin Area Flood Control ...
NEW YORK--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq:URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of uro-oncology, today announced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback